Prenatal Screener Natera Grabs $55M Considers Cancer Test
Apr 6, 2015, 00:00 AM
by
Michael Croft
Xconomy | In the increasingly active genetic
testing space, Natera is trying to lead the pack by harnessing its
testing capabilities, thanks to a new $55.5 million funding round.
April 06, 2015 | In the increasingly active genetic testing space, Natera is trying to lead the pack by harnessing its testing capabilities, thanks to a new $55.5 million funding round. Xconomy